Experts ID new treatment for type 1 diabetes

12/20/2011 | Sydney Morning Herald (Australia), The

The depletion of heparan sulphate, a type of complex sugar, triggers the destruction of insulin-producing beta cells, a study in The Journal of Clinical Investigation showed. Researchers also found that autoimmune cells produce the enzyme heparanase, which degrades heparan sulphate in beta cells. "This has revealed a new understanding of the development of type 1 diabetes and has identified a new therapeutic strategy for preventing progression of the autoimmune disease and associated complications," researcher Dr. Charmaine Simeonovic said.

View Full Article in:

Sydney Morning Herald (Australia), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC